@article {4572,
	title = {Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.},
	journal = {Journal of hepatology},
	volume = {62},
	year = {2015},
	month = {2015 Feb},
	pages = {286-93},
	abstract = {The safety profiles of boceprevir and telaprevir in the treatment of chronic hepatitis C, administered in academic and community centres across the United States, were evaluated.},
	keywords = {Adolescent, Adult, Aged, Antiviral Agents, DNA, Viral, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Follow-Up Studies, Genotype, Hepacivirus, Hepatitis C, Chronic, Humans, Male, Middle Aged, Oligopeptides, Proline, Retrospective Studies, Treatment Outcome, Viral Load, Young Adult},
	issn = {1600-0641},
	doi = {10.1016/j.jhep.2014.08.052},
	author = {Gordon, Stuart C and Muir, Andrew J and Lim, Joseph K and Pearlman, Brian and Argo, Curtis K and Ramani, Ananthakrishnan and Maliakkal, Benedict and Alam, Imtiaz and Stewart, Thomas G and Vainorius, Monika and Peter, Joy and Nelson, David R and Fried, Michael W and Reddy, K Rajender}
}
